Pii Expands Manufacturing Capabilities

The new MG2 G140 capsule filler has an output rate of as many as 140,000 capsules per hour and can dose powder and pellets.

Pharmaceutics International Inc. (Pii) has added an MG2G140 capsule filler to its solid oral GMP manufacturing area to expand its existing commercial manufacturing capabilities. The MG2 G140 capsule filler has an output rate of as many as 140,000 capsules per hour and can dose powder and pellets.

Steve King, senior vice president of Pii said, “Expanding our large-scale manufacturing capabilities with the addition of the MG2 G140 demonstrates Pii’s commitment to enhancing and growing the commercial services provided to our customers. This new capability allows us to better meet the needs of customers in the late and commercial stages of drug development.”